{"type":"profile","id":"profile=compamed2026.3070051","exhSeoId":"ht4FY9qiTAmClCQf0OHtCA","name":"Smart Reactors Ltd.","email":"Brian@smartreactors.com","getInTouchEmail":"Brian@smartreactors.com","profileAddress":{"address":["1st, Floor, Block 15 Galway Technology Park, Parkmore Road"],"city":"Galway","zip":"H91AY0Y","country":"Ireland","countryCode":"IE"},"phone":{"phone":"+353 353 0852299274"},"links":[{"id":"link=HMma2w5uRcWNqrR94kV6CA","type":"link","link":"https://www.smartreactors.com","parentType":"profile","order":1,"visibleInLang":["en","de"]}],"media":[{"id":"video=JuZILi8lTGqeHR2PvuMCtw","type":"video","title":"Advanced Medical Device Coatings","text":"At Smart Reactors, we specialise in the development of advanced coating technologies for medical devices. Based in Galway, Ireland, we work with medical device companies around the world to develop coating solutions that improve device performance and address important clinical challenges. Our focus is simple: understand the device, understand the clinical need and develop the right surface technology to meet it. Smart Reactors was established to bring innovative coating technologies from early-stage research through to commercial medical device applications. We work closely with our customers throughout the entire development process, from initial feasibility and coating selection through development, testing, scale-up and ultimately manufacturing transfer. Our objective is not simply to supply a coating; we want to become a development partner to our customers. Every medical device presents a different challenge, and factors such as the substrate, geometry, manufacturing process, sterilisation method and intended clinical application can all influence how a coating needs to perform. That is why Smart Reactors takes a device-specific approach to coating development. When a customer comes to us, we first look at the device and the specific performance they are trying to achieve. We then assess the materials, device geometry and manufacturing process before selecting or developing the appropriate coating technology. Smart Reactors combines coating chemistry, materials science, medical device engineering and biological testing to evaluate coating performance throughout the development process and optimise the technology specifically for the customer's device. A key part of our development process is understanding how the coating interacts with both the device and the biological environment. We carry out structured development and testing programmes to understand coating coverage, durability and performance, applying the coating, testing it, analysing the results and continually optimising the process until the required performance is achieved. Collaboration is central to the Smart Reactors approach, with our scientists and engineers working directly with customer R&D teams to solve coating and surface-related challenges. Projects can begin with a single device or feasibility study and progress through optimisation, validation and preparation for commercial manufacture. One of the major challenges in medical device coating development is ensuring that what works at laboratory scale can also work consistently in manufacturing. During development, we therefore consider the complete process, including equipment, coating parameters, materials, quality controls and testing. For us, successful development means much more than demonstrating that a coating works. It needs to be reproducible, scalable, compatible with the customer's manufacturing process and capable of supporting the regulatory pathway for the finished medical device. Once the coating and process have been finalised, we document the complete manufacturing process, defining the critical process parameters, equipment requirements, quality controls and testing requirements needed to consistently produce the coated device. Smart Reactors then prepares a comprehensive technology transfer package and can work directly with the customer's manufacturing facility to install and transfer the coating process, train personnel and ensure that the coated device can be manufactured consistently. Ultimately, our role is to help medical device companies bring better technologies to patients. We combine coating science with medical device development and manufacturing experience to take technologies from concept through to commercial production, providing an end-to-end coating development solution for the medical device industry. Smart Reactors — Leaders in Medical Device Coatings.","parentType":"profile","videoId":"1231310973","videoBlindSuitable":false,"videoDeafSuitable":false,"videoUploaded":true,"videoHasTexttrack":false,"order":1,"visibleInLang":["en","de"]},{"id":"video=RGHEd2cjQXKUyP7vlMpZrQ","type":"video","title":"Enhancing Neurovascular Devices with Camouflage™","parentType":"profile","videoId":"1231313196","videoBlindSuitable":true,"videoDeafSuitable":true,"videoUploaded":true,"videoHasTexttrack":false,"order":2,"visibleInLang":["en","de"]}],"locations":[{"areaId":"08B","area":"Hall 8b","stand":"J33"}],"location":"Hall 8b / J33","locationIsVirtual":false,"events":[{"key":"compamed2026","label":"COMPAMED 2026"}],"eventIcons":[{"label":"COMPAMED 2026","src":"https://www.medica.de/vis-content/event-compamed2026/all-exh/Event-ZFtZiiP4RMiOWEze9Zi3pA.png"}],"eventMap":"https://iahapla02.messe-duesseldorf.de/en/2dexgroundV2/compamed2026/3070051.svg","areaMap":"https://iahapla02.messe-duesseldorf.de/en/3dhallV2/compamed2026/08B/3070051.svg","areaId":"08B","premium":false,"exhIsLead":false,"logoUploadedByPubimport":false,"tags":[{"id":"tag=compamed2026.1","label":"Service","icon":"md md-tag-label md-tag-label-s"}],"xtags":[],"socialMedia":[{"title":"WhatsApp","link":"https://wa.me/","network":"whatsapp","standardDomain":"https://wa.me/"},{"title":"YouTube","link":"https://www.youtube.com/","network":"youtube","standardDomain":"https://www.youtube.com/"},{"title":"LinkedIn","link":"https://www.linkedin.com/","network":"linkedin","standardDomain":"https://www.linkedin.com/"}],"synonyms":[],"text":"<p>Smart Reactors is a Galway-based medical technology company specialising in advanced surface and coating technologies for medical devices. Founded in 2019, the company combines expertise in medical devices, polymer chemistry, biomaterials and surface science to address some of the key challenges associated with blood-contacting and implantable devices.</p><p>The company&#8217;s flagship technology,&#160;<strong>Camouflage™</strong>, is a proprietary hemocompatible coating designed to improve the interaction between medical devices and circulating blood. The ultra-thin, passive, non-heparin coating is designed to reduce thrombus formation and inflammatory response while supporting endothelialisation and longer-term healing.</p><p>A significant milestone for Smart Reactors was the&#160;<strong>FDA 510(k) clearance of the Camouflage™ Coated Extracorporeal Cardiopulmonary Circuit Tubing Set</strong>, indicated for cardiopulmonary bypass procedures for up to six hours. This represents an important validation of technology developed in Galway and its progression towards commercial medical-device applications.</p><p>Building on Camouflage™, Smart Reactors is developing a broader portfolio of advanced medical-device surface technologies across three core areas:&#160;<strong>hemocompatible, hydrophilic and antimicrobial coatings</strong>. The company has a particular focus on cardiovascular and neurovascular applications, including flow diverters, intracranial and vascular stents, catheters, guidewires, vascular grafts, structural heart devices, ECMO, cardiopulmonary bypass and other blood-contacting technologies.</p><p>Smart Reactors works directly with medical-device manufacturers from early-stage development through to commercialisation. Its capabilities include coating selection and feasibility, prototype coating, design and development, testing, process optimisation, manufacturing transfer and scale-up, regulatory support and ongoing technical support.</p><p>Headquartered in&#160;<strong>Galway, Ireland</strong>, Smart Reactors works with medical-device companies internationally and commercialises its technologies through development partnerships, technology licensing and long-term supply arrangements. Its ambition is to establish Galway as a centre for the development and commercialisation of next-generation medical-device surface technologies.</p><p><strong>Smart Reactors – Advanced Coating Technologies for the Next Generation of Medical Devices.</strong></p>","businessData":[{"id":"staff","type":"category","title":"Number of employees","values":[{"id":"staff=compamed2026.1","label":"1-19"}]}],"pdfs":[{"id":"paper=6uQTgcC6S3aYx8SAG4HdyQ","type":"paper","title":"Brochure-Perfusion & Dialysis","source":"https://www.medica.de/vis-content/event-compamed2026/exh-compamed2026.3070051/COMPAMED-2026-Smart-Reactors-Ltd.-Paper-compamed2026.3070051-mgJ5NF8iTA2ulpUp9f7OJw.pdf","parentType":"profile","fileName":"Brochure-Perfusion & Dialysis.pdf","order":1,"visibleInLang":["en","de"]}],"tol":[],"categories":[{"id":"prod=compamed2026.04.09.02","label":"Medical Device Classification","catalogIndex":"04.09.02","eventIcons":[{"key":"compamed2026","small":"https://www.medica.de/vis-content/event-compamed2026/all-exh/Event-AVaFlSsfTmOWHN67ovdRaA.png","tiny":"https://www.medica.de/vis-content/event-compamed2026/all-exh/Event-ZFtZiiP4RMiOWEze9Zi3pA.png","label":"COMPAMED 2026"}],"productList":[],"hierarchy":[{"id":"04","label":"Compliance, Quality, Regulation & Market Access"},{"id":"04.09","label":"Segmentation by Regulatory Stage"},{"id":"04.09.02","label":"Medical Device Classification"}]}],"write":false,"lastModified":"2026-11-03T22:32:00Z","tagsAreEditable":false,"xtagsAreEditable":false,"isGetInTouchAllowed":false}